BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Total Liabilities (Quarterly) : 2.055M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.055M |
| March 31, 2026 | 2.778M |
| December 31, 2025 | 2.518M |
| September 30, 2025 | 3.521M |
| June 30, 2025 | 3.975M |
| March 31, 2025 | 3.686M |
| December 31, 2024 | 2.887M |
| September 30, 2024 | 3.514M |
| June 30, 2024 | 4.851M |
| March 31, 2024 | 4.954M |
| December 31, 2023 | 4.59M |
| September 30, 2023 | 4.407M |
| June 30, 2023 | 4.754M |
| March 31, 2023 | 5.228M |
| December 31, 2022 | 4.901M |
| September 30, 2022 | 5.082M |
| June 30, 2022 | 4.532M |
| March 31, 2022 | 5.471M |
| December 31, 2021 | 5.343M |
| September 30, 2021 | 3.918M |
| June 30, 2021 | 4.545M |
| March 31, 2021 | 4.746M |
| December 31, 2020 | 4.248M |
| September 30, 2020 | 5.389M |
| June 30, 2020 | 5.837M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.667M |
| December 31, 2019 | 5.308M |
| September 30, 2019 | 5.487M |
| June 30, 2019 | 4.952M |
| March 31, 2019 | 4.339M |
| December 31, 2018 | 2.625M |
| September 30, 2018 | 2.612M |
| June 30, 2018 | 1.903M |
| March 31, 2018 | 2.204M |
| December 31, 2017 | 2.413M |
| September 30, 2017 | 2.075M |
| June 30, 2017 | 1.675M |
| March 31, 2017 | 1.43M |
| December 31, 2016 | |
| September 30, 2016 | 0.33M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.01M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.004M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.001M |
| September 30, 2014 | 0.005M |
| June 30, 2014 | 0.001M |
| March 31, 2014 | 0.001M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cytokinetics, Inc. | 2.098B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.755M |
| Shareholders Equity (Quarterly) | 2.70M |
| Debt to Equity Ratio | 0.1085 |
| Current Ratio | 2.092 |
| Net Debt Paydown Yield | 0.60% |